Abstract:Linlin Zhao, 1, 2 Man Cui, 3 Saiqi Yang, 1, 2 Hui Zhou, 1, 2 Meng Li 4 1 Health Management Medicine Center, The Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China; 2 Health Management Research Center, Central South University, Changsha, Hunan, People's Republic of China; 3 Department of Medical Administration, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People's Republic of China; 4 Department of Endocrinology, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People's Republic of China Correspondence: Meng Li, Email Objective: This retrospective cohort study was designed to evaluate the association between eight systemic inflammation indicators at baseline and the metabolically unhealthy (MU) phenotype after two years of follow-up. Methods: Participants were defined as metabolically healthy (MH) if they met 0– 2 of the criteria and metabolically unhealthy (MU) if they met ≥ 3 of the criteria. A many of 4175 subjects aged 20– 80 years with a metabolically healthy (MH) phenotype at baseline were enrolled in the study. We compared the clinical characteristics between women and men enrolled at baseline according to the metabolic phenotype at follow-up. The associations between baseline inflammation indicators and MU status at follow-up were evaluated using logistic regression analysis. Results: 922 (22.08%) developed new-onset MU symptoms during follow-up. Logistic regression analysis found that most inflammation indicators were significantly associated with MU phenotype at follow-up, aside from the LMR and SII. After adjusting for potential confounders, only the correlations between CRP level, neutrophil count, and MU phenotype reached significance. In comparison to the control group with a CRP of < 0.50 mg/L, the odds ratios (ORs) and 95% confidence intervals (CIs) were 1.61 (1.25– 2.09), 1.49 (1.15– 1.94), and 1.68 (1.30– 2.18) for individuals with CRP levels of 0.50– 0.90 mg/L, 0.91– 1.72 mg/L, and above 1.72 mg/L, respectively. In the population with a neutrophil count < 5.00 × 10 9 cells/L, the neutrophil count correlated positively and significantly with the MU phenotype. In comparison to the control group with a neutrophil count of < 2.75 × 10 9 cells/L, the ORs and 95% CIs were 1.65 (1.30– 2.09) in the population with neutrophil count > 4.17 × 10 9 cells/L. Conclusion: CRP and neutrophil counts positively correlated with the risk of MU phenotype in Chinese subjects. These composite inflammatory markers (NLR, PLR, LMR, and SII) provide limited advantages for predicting MU risks compared to CRP. Keywords: systemic inflammation indicators, metabolically unhealthy phenotype, C-reactive protein, CRP Obesity is linked to various metabolic issues, including insulin resistance, high blood lipid levels, and metabolic syndrome, all of which are significant factors in the development of type 2 diabetes (T2D) and cardiovascular diseases (CVDs). Nevertheless, there are obese individuals who do not experience the usual negative effects of having too much body fat 1 a condition referred to as metabolically healthy obesity (MHO). 2 Increasing studies are now being directed to MHO in recent years. The concept of MHO is still evolving, with no agreement on its definition as more than 30 different definitions have been utilized in various studies. 2 Most studies have defined MHO as having 2 or fewer metabolic syndrome components. 3 Additional criteria less commonly used to define MHO are C-reactive protein level and insulin resistance. 4 Nevertheless, the metabolically healthy (MH) phenotype is not stable, and long-term research findings indicate that approximately 16.6% to 50% of individuals with mental health conditions shift to a different phenotype after a decade to two decades of observation. 5–7 In general, metabolically unhealthy (MU) participants are at an increased risk of ischemic stroke, 1 T2D, 8 and colorectal cancer 9 than MH participants, and have a better prognosis for mortality and morbidity. 10 The transition of metabolic phenotype depends on a multitude of factors such as age, 11 liver function, 12 glucose regulation, lifestyle 13 and gut microbiome. 14 Timely recognition of metabolic risk factors is required to ensure optimal primary interventions and decrease healthcare costs. Recently, there is a lot of attention given to the relationship between inflammation and -Abstract Truncated-

Metabolic Inflammatory Syndrome: a Novel Concept of Holistic Integrative Medicine for Management of Metabolic Diseases

Characteristics of Metabolic Inflammatory Syndrome among Inpatients with Type 2 Diabetes: A Cross-Sectional Study in China.

High Detective Rate Of"metabolic Inflammatory Syndrome"in Patients with Type 2 Diabetes

A Non-invasive Model for Detection of Undiagnosed Metabolic Syndrome in School Children and Adolescents

An Augmented Model with Inferred Blood Features for the Self-diagnosis of Metabolic Syndrome.

Comparative Study on Prevalence of Metabolic Syndrome Based on Three Criteria among Adults in Zhejiang Province, China: an Observational Study.

Metabolic Syndrome in the Prevention of Cardiovascular Diseases and Diabetes—still a Matter of Debate?

Metabolic syndrome and its individual components with mortality among patients with coronary heart disease

Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease

A multi-omics investigation of the molecular characteristics and classification of six metabolic syndrome relevant diseases

Association between dietary inflammatory index and metabolic syndrome: Analysis of the NHANES 2005–2016

Identification of Novel Metabolic Subtypes Using Multi-Trait Limited Mixed Regression in the Chinese Population

Systemic Inflammatory Indicators and Risk of Incident Metabolically Unhealthy Phenotype

Key Correlated Pathologies and Non-Invasive Diagnostic Approaches

Modeling of diagnosis for metabolic syndrome by integrating symptoms into physiochemical indexes

Enhancing the Treatment of Metabolic Syndrome with Integrative Medicine.

Multi-stage metabolomics and genetic analyses identified metabolite biomarkers of metabolic syndrome and their genetic determinants

The prevalence and characteristics of metabolic syndrome according to different definitions in China: a nationwide cross-sectional study, 2012–2015

Identification of Cardiovascular Risk Components in Urban Chinese with Metabolic Syndrome and Application to Coronary Heart Disease Prediction: A Longitudinal Study

Identifying Metabolic Syndrome Easily and Cost Effectively Using Non-Invasive Methods with Machine Learning Models

Identification of Traditional Chinese Medicine Constitutions and Physiological Indexes Risk Factors in Metabolic Syndrome: A Data Mining Approach